Safety of protocol violations in acute stroke tPA administration.
Lyerly, Michael J
Safety of protocol violations in acute stroke tPA administration. [electronic resource] - Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association - 855-60 p. digital
Publication Type: Journal Article
1532-8511
10.1016/j.jstrokecerebrovasdis.2013.07.019 doi
Adult
Aged
Aged, 80 and over
Alabama
Antihypertensive Agents--standards
Blood Coagulation Tests--standards
Chi-Square Distribution
Cross-Sectional Studies
Female
Fibrinolytic Agents--administration & dosage
Guideline Adherence--standards
Hemorrhage--chemically induced
Humans
Logistic Models
Male
Middle Aged
Odds Ratio
Outcome and Process Assessment, Health Care--standards
Patient Admission--standards
Patient Safety--standards
Patient Selection
Practice Guidelines as Topic--standards
Practice Patterns, Physicians'--standards
Registries
Retrospective Studies
Risk Assessment
Risk Factors
Thrombolytic Therapy--adverse effects
Time-to-Treatment--standards
Tissue Plasminogen Activator--administration & dosage
Treatment Outcome
Young Adult
Safety of protocol violations in acute stroke tPA administration. [electronic resource] - Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association - 855-60 p. digital
Publication Type: Journal Article
1532-8511
10.1016/j.jstrokecerebrovasdis.2013.07.019 doi
Adult
Aged
Aged, 80 and over
Alabama
Antihypertensive Agents--standards
Blood Coagulation Tests--standards
Chi-Square Distribution
Cross-Sectional Studies
Female
Fibrinolytic Agents--administration & dosage
Guideline Adherence--standards
Hemorrhage--chemically induced
Humans
Logistic Models
Male
Middle Aged
Odds Ratio
Outcome and Process Assessment, Health Care--standards
Patient Admission--standards
Patient Safety--standards
Patient Selection
Practice Guidelines as Topic--standards
Practice Patterns, Physicians'--standards
Registries
Retrospective Studies
Risk Assessment
Risk Factors
Thrombolytic Therapy--adverse effects
Time-to-Treatment--standards
Tissue Plasminogen Activator--administration & dosage
Treatment Outcome
Young Adult